Search

Abstract Background Ropinirole has been shown to provoke vomiting in dogs by activating the dopamine D2‐like receptors in the chemoreceptor trigger zone. In humans, ropinirole is metabolized primarily by CYP1A2. Corresponding dog CYP1A2 is known to be a polymorphic enzyme which can cause variation in pharmacokinetics of compounds metabolised via this enzyme. Objectives The aim of this study was to understand metabolic clearance of ropinirole in dogs, the enzymes involved in ropinirole metabolism and specially to estimate whether the clearance can be sensitive towards the polymorphism of canine CYP1A2. Methods Metabolism of ropinirole was studied in dog hepatocytes and specific recombinant canine CYP isoforms. Metabolite identification and metabolite formation were evaluated using LC–mass spectrometry. Results Ropinirole was moderately stable in dog hepatocytes with Clint of 16.3 μL/min/million cells, and the metabolites detected were 7‐hydroxy ropinirole and respective glucuronide conjugate as well as despropyl ropinirole. Regarding recombinant CYPs either 7‐hydroxy ropinirole, despropyl ropinirole or both were detected for each CYP isoform studied. The highest rates of metabolite formation were observed in CYP2B11, CYP2C21, CYP2D15, CYP1A2 and CYP1A1. Fluvoxamine, a fairly selective human CYP1A/CYP2C19 inhibitor inhibited ropinirole metabolism by CYP1A1, CYP1A2, CYP2B11, CYP2C21 and CYP2D15 for 65.8%–100% showing no selectivity towards canine CYP isoforms. Conclusions Although human metabolism of ropinirole is mainly mediated through CYP1A2, the current study shows that several canine CYP isoforms are able to contribute to the clearance of ropinirole in dogs. This is expected to reduce a possible impact of canine CYP1A2 polymorphism on ropinirole pharmacokinetics.

Abstract Background Carbon capture using alkaliphilic cyanobacteria can be an energy-efficient and environmentally friendly process for producing bioenergy and bioproducts. The inefficiency of current harvesting and downstream processes, however, hinders large-scale feasibility. The high alkalinity of the biomass also introduces extra challenges, such as potential corrosion, inhibitory effects, or contamination of the final products. Thus, it is critical to identify low cost and energy-efficient downstream processes. Results Autofermentation was investigated as an energy-efficient and low-cost biomass pre-treatment method to reduce pH to levels suitable for downstream processes, enabling the conversion of cyanobacterial biomass into hydrogen and organic acids using cyanobacteria’s own fermentative pathways. Temperature, initial biomass concentration, and oxygen presence were found to affect yield and distribution of organic acids. Autofermentation of alkaline cyanobacterial biomass was found to be a viable approach to produce hydrogen and organic acids simultaneously, while enabling the successful conversion of biomass to biogas. Between 5.8 and 60% of the initial carbon was converted into organic acids, 8.7–25% was obtained as soluble protein, and 16–72% stayed in the biomass. Interestingly, we found that extensive dewatering is not needed to effectively process the alkaline cyanobacterial biomass. Using natural settling as the only harvesting and dewatering method resulted in a slurry with relatively low biomass concentration. Nevertheless, autofermentation of this slurry led to the maximum total organic acid yield (60% C mol/C mol biomass) and hydrogen yield (326.1 µmol/g AFDM). Conclusion Autofermentation is a simple, but highly effective pretreatment that can play a significant role within a cyanobacterial-based biorefinery platform by enabling the conversion of alkaline cyanobacterial biomass into organic acids, hydrogen, and methane via anaerobic digestion without the addition of energy or chemicals.

Weldenegodguad et al. performed transcriptome profiling of adipose tissues from the bone marrow, perirenal, and prescapular fat in Finnish and Even reindeer (in Sakha) during spring and winter. They identified candidate genes potentially involved in immune responses, fat deposition, and energy metabolism that provide insight into the mechanisms by which reindeer adapt to harsh arctic conditions.

Abstract Background Modern metal-on-metal (MOM) arthroplasties were performed for over a decade before alarming reports of adverse metal reactions dramatically reduced their use. Failures are seen more often with high-wearing implants, but also well-positioned components with more favourable wear patterns can cause problems. There are no specific clinical indicators that could help us to predict the prognosis of these implants. For this reason, we still need more information on the effect of underlying factors that contribute to this process. Methods In this prospective cohort study, we investigated how cup orientation and type of pseudotumour determined by the Hart classification effect the distribution of metals in blood, synovial fluid and tissues surrounding the metal-on-metal hip prosthesis in revision surgery patients. One thousand two hundred twenty-nine metal-on-metal hip patients were screened and of those, 60 patients that had a revision surgery due to adverse metal reaction were included. Whole blood, synovial fluid and synovial/pseudotumour tissue samples were analysed for metal ion concentrations (Co, Cr, Mo and Ti). Results The lowest metal concentrations were found when both cup anteversion and inclination were optimal, and the highest when both were suboptimal. Suboptimal anteversion alone raised Cr-ion concentrations more than suboptimal inclination. The concentrations of metals in blood, synovial fluid or synovial soft tissue were the same in patients with and without a pseudotumour, but the relative transfer percentage of cobalt from synovial fluid to blood was higher in patients with a pseudotumour. Conclusions The implant orientation alone does not explain the metal concentrations found in tissues or distribution of metals between different tissues. The accumulation of metals in periprosthetic soft tissues increase the total metal load, and in the presence of a pseudotumour this is reflected in the transfer ratio of Co from synovial fluid to the blood. The total metal load of the pseudotumour tissue should be defined in future studies to determine if this will provide new insights for clinical practice.

Background: Ropinirole has been shown to provoke vomiting in dogs by activating the dopamine D2‐like receptors in the chemoreceptor trigger zone. In humans, ropinirole is metabolized primarily by CYP1A2. Corresponding dog CYP1A2 is known to be a polymorphic enzyme which can cause variation in pharmacokinetics of compounds metabolised via this enzyme. Objectives: The aim of this study was to understand metabolic clearance of ropinirole in dogs, the enzymes involved in ropinirole metabolism and specially to estimate whether the clearance can be sensitive towards the polymorphism of canine CYP1A2. Methods: Metabolism of ropinirole was studied in dog hepatocytes and specific recombinant canine CYP isoforms. Metabolite identification and metabolite formation were evaluated using LC–mass spectrometry. Results: Ropinirole was moderately stable in dog hepatocytes with Clint of 16.3 μL/min/million cells, and the metabolites detected were 7‐hydroxy ropinirole and respective glucuronide conjugate as well as despropyl ropinirole. Regarding recombinant CYPs either 7‐hydroxy ropinirole, despropyl ropinirole or both were detected for each CYP isoform studied. The highest rates of metabolite formation were observed in CYP2B11, CYP2C21, CYP2D15, CYP1A2 and CYP1A1. Fluvoxamine, a fairly selective human CYP1A/CYP2C19 inhibitor inhibited ropinirole metabolism by CYP1A1, CYP1A2, CYP2B11, CYP2C21 and CYP2D15 for 65.8%–100% showing no selectivity towards canine CYP isoforms. Conclusions: Although human metabolism of ropinirole is mainly mediated through CYP1A2, the current study shows that several canine CYP isoforms are able to contribute to the clearance of ropinirole in dogs. This is expected to reduce a possible impact of canine CYP1A2 polymorphism on ropinirole pharmacokinetics. [ABSTRACT FROM AUTHOR]

This study presents the potential of combining anaerobic grey water sludge treatment with black water in an up-flow anaerobic sludge blanket (UASB) reactor to improve energy recovery within source-separated sanitation concepts. Black water and the mixture of black water and grey water sludge were compared in terms of biochemical methane potential (BMP), UASB reactor performance, chemical oxygen demand (COD) mass balance and methanization. Grey water sludge treatment with black water increased the energy recovery by 23% in the UASB reactor compared to black water treatment. The increase in the energy recovery can cover the increased heat demand of the UASB reactor and the electricity demand of the grey water bioflocculation system with a surplus of 0.7 kWh/cap/y electricity and 14 MJ/cap/y heat. However, grey water sludge introduced more heavy metals in the excess sludge of the UASB reactor and might therefore hinder its soil application.

Separation of different domestic wastewater streams and targeted on-site treatment for resource recovery has been recognized as one of the most promising sanitation concepts to re-establish the balance in carbon, nutrient and water cycles. In this study a model was developed based on literature data to compare energy and water balance, nutrient recovery, chemical use, effluent quality and land area requirement in four different sanitation concepts: (1) centralized; (2) centralized with source-separation of urine; (3) source-separation of black water, kitchen refuse and grey water; and (4) source-separation of urine, feces, kitchen refuse and grey water. The highest primary energy consumption of 914 MJ/capita(cap)/year was attained within the centralized sanitation concept, and the lowest primary energy consumption of 437 MJ/cap/year was attained within source-separation of urine, feces, kitchen refuse and grey water. Grey water bio-flocculation and subsequent grey water sludge co-digestion decreased the primary energy consumption, but was not energetically favorable to couple with grey water effluent reuse. Source-separation of urine improved the energy balance, nutrient recovery and effluent quality, but required larger land area and higher chemical use in the centralized concept.

We replaced a control peat medium with up to 75% biochar on a volumetric basis in three different forms (powder, BC; pyrolyzed softwood pellets, PP; composite wood-biochar pellets, WP), and under two supplies of nitrogen fertilizer (20 or 80 mg N) subsequently grew seedlings with a comparable morphology to the control. Using gravimetric methods to determine irrigation frequency and exponential fertilization to ensure all treatments received the same amount of N at a given point in the growing cycle, we successfully replaced peat with 25% BC and up to 50% PP. Increasing the proportion of biochar in the media significantly increased pH and bulk density and reduced effective cation exchange capacity and air-filled porosity, although none of these variables was consistent with resultant seedling growth. Adherence to gravimetric values for irrigation at an 80% water mass threshold in the container revealed that the addition of BC and WP, but not PP, required adjustments to the irrigation schedule. For future studies, we encourage researchers to provide more details about bulk density, porosity, and irrigation regime to improve the potential inference provided by this line of biochar and growing media work.